Novel Insights On Sglt 2 Inhibitors
₹2,559
₹3,199
20% OffFinal Price inclusive of all taxes
Cash on Delivery
Free Delivery
Get it delivered in 3-6 days
size
114 Pages
Product Information
Brand
SRKBA
Ideal For
Medical Students & Healthcare Professionals
Country Of Origin
India
Pack Of
1
Type
Book
Binding
Paperback
Copyright Year
2020
Edition
1st Edition
Isbn
9789352706808
Language
English
Pages
114
Publisher
JPB
Product Description
- This Book Provides Detailed Information On The Novel Drug Class Sglt: 2 Inhibitors For The Treatment Of Diabetes.
- Feature: All Current Evidences, Studies And Available Data Have Been Incorporated In The Writing Of This Book To Bring To The Readers An Updated Overview Of This Novel Drug Class.
- An In Depth Search Of Literature On All Topics Traces How The Sglt: 2 Inhibitors Have Evolved And Are Now A Preferred Option In Management Of Type 2 Diabetes, With Promising Data Emerging On Their Use In Type 1 Diabetes As Well.
- Feature: The Book Has Been Written In Simple Language And A Standard Pattern With A Crisp Introduction Of The Topic To Brief The Reader On What To Expect In The Text, Followed At The End By A Short Conclusion That Sums Up The Text For Quick Reference Of Its Readers
- Feature: The Book Is Aimed At All Health Care Practitioners, Physicians And Medical Students/Postgraduates With An Avid Interest In The Latest Advances In The Evolution Of This Drug Class For Diabetes Management
- Feature: Written By Experts In The Field Of Diabetes With A Vast Clinical Experience With These Agents.